Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Intel Stock Surges as Nvidia Makes Surprise $5 Billion Bet

Dieter Jaworski by Dieter Jaworski
September 28, 2025
in Stocks
0
Intel Stock
0
SHARES
98
VIEWS
Share on FacebookShare on Twitter

In a stunning strategic pivot, Nvidia has committed a $5 billion investment into its long-standing rival, Intel. This unexpected move by the AI chip leader has ignited a powerful rally in Intel’s share price, signaling a potential turning point for the company’s foundry ambitions. The development raises a critical question: is this the catalyst that will finally steer Intel back to a position of strength?

A Vote of Confidence from an Unlikely Source

The announcement marks a significant departure from the historical rivalry between the two semiconductor giants. For years, Nvidia has relied on competitors like TSMC for its manufacturing needs. The substantial $5 billion commitment, however, is being interpreted by the market as far more than a simple financial investment; it is a powerful endorsement of Intel’s foundry services and its strategic importance to the U.S. chip supply chain.

The reaction on Wall Street was immediate and forceful. Intel’s stock price experienced a sharp upward surge following the news. Market experts suggest that Nvidia’s decision validates the core argument Intel CEO Pat Gelsinger has been making for months: the United States requires a robust, domestic semiconductor manufacturing capability.

Broadening Alliances: Apple and TSMC in Talks

The potential partnerships extend beyond Nvidia. Intel is reportedly engaged in advanced discussions with other technology leaders, including Apple and the Taiwanese semiconductor powerhouse, TSMC. These parallel negotiations indicate a fundamental strategic shift for Intel, transforming its role from a pure-play competitor to a potential manufacturing partner for the industry’s biggest names.

Should investors sell immediately? Or is it worth buying Intel?

A collaboration with Apple is particularly significant. Such a deal could see the iPhone maker producing a portion of its custom chips within Intel’s U.S.-based fabrication plants, an arrangement that would fundamentally reshape global supply chain dynamics.

Geopolitical Tailwinds Provide Additional Support

The current geopolitical climate is creating favorable conditions for Intel’s resurgence. Two major factors are at play:
* Government Subsidies: The CHIPS Act has earmarked over $8 billion in direct subsidies for Intel to build new fabrication plants.
* Trade Protection: Potential new tariffs on imported semiconductors could create a protective barrier for domestic producers.

These government initiatives are designed to bolster national semiconductor production and reduce reliance on foreign suppliers, directly benefiting Intel’s expansion plans.

Technical Chart Signals a Major Reversal

From a technical analysis perspective, Intel’s stock has broken out of a prolonged downtrend. After months of weakness, the share price has decisively overcome key resistance levels. Notably, the 200-day moving average, which previously acted as a ceiling, has now flipped to become a solid floor of support. This technical breakout, culminating in a 45% surge in September and a new 52-week high of $36.30, mirrors the shifting fundamental outlook for the company. The market is signaling that Intel is once again a serious contender in the future of chip manufacturing.

Ad

Intel Stock: Buy or Sell?! New Intel Analysis from February 7 delivers the answer:

The latest Intel figures speak for themselves: Urgent action needed for Intel investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Intel: Buy or sell? Read more here...

Tags: Intel
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Take-Two Stock

Take-Two Interactive Shares Surge to Record High on Industry Optimism

Ocugen Stock

Ocugen Faces Strategic Crossroads After $25 Million Merger Deal Collapses

IBM Stock

IBM's Quantum Leap: Banking Breakthrough Sparks Investor Interest

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com